Impact of Hyperglycemia and Diabetes Mellitus on Breakthrough Mucormycosis Outcomes in Patients with Hematologic Malignancies-Complex and Intriguing Associations.

Franklin, Alexander; Wurster, Sebastian; Axell-House, Dierdre B; Jiang, Ying; Kontoyiannis, Dimitrios P

Franklin, Alexander; Wurster, Sebastian; Axell-House, Dierdre B; Jiang, Ying; Kontoyiannis, Dimitrios P.

Afiliação

Franklin A; Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Wurster S; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Axell-House DB; Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jiang Y; Division of Infectious Diseases, Houston Methodist Hospital and Houston Methodist Research Institute, Houston, TX 77030, USA.
Kontoyiannis DP; Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

J Fungi (Basel) ; 9(1)2022 Dec 28.

Article em En | MEDLINE | ID: mdl-36675866

Palavras-chave

diabetes mellitus; hematologic malignancy; hyperglycemia; insulin; mortality; mucormycosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article